We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+34.9%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$492M
AUM Growth
+$152M
(+45%)
Cap. Flow
+$82.8M
Cap. Flow
% of AUM
16.83%
Top 10 Holdings %
Top 10 Hldgs %
34.01%
Holding
98
New
29
Increased
22
Reduced
16
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$8.41M |
| 2 |
Arista Networks
ANET
|
+$7.11M |
| 3 |
Atlassian
TEAM
|
+$7.05M |
| 4 |
Madison Square Garden
MSGS
|
+$6.69M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$6.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$6.7M |
| 2 |
eHealth
EHTH
|
+$5.9M |
| 3 |
UnitedHealth
UNH
|
+$5.61M |
| 4 |
ALLK
Allakos
ALLK
|
+$4.7M |
| 5 |
Five Below
FIVE
|
+$4.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.63% |
| 2 | Technology | 16.49% |
| 3 | Communication Services | 10% |
| 4 | Consumer Discretionary | 6.21% |
| 5 | Materials | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$455B
| $47.1M | 9.56% |
262,000
+152,000
| +138% | +$25.8M |
|
2
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $19.1M | 3.89% |
+125,000
| New | +$18.8M |
|
3
PUT
Apple
AAPL
$4.89T
| $17.1M | 3.47% |
+360,000
| New | +$15.3M |
|
|
EXAS
4
DELISTED
Exact Sciences
EXAS
| $13.7M | 2.78% |
158,000
+7,500
| +5% | +$638K |
|
5
PUT
iShares MSCI EAFE ETF
EFA
$76.4B
| $13M | 2.64% |
+200,000
| New | +$12.6M |
|
|
6
Arista Networks
ANET
$219B
| $12.6M | 2.56% |
640,000
+448,000
| +233% | +$7.11M |
|
7
Okta
OKTA
$24.1B
| $12.2M | 2.47% |
147,000
+13,000
| +10% | +$1.03M |
|
8
Netflix
NFLX
$292B
| $11.4M | 2.32% |
320,000
-10,000
| -3% | -$347K |
|
9
Sarepta Therapeutics
SRPT
$1.66B
| $10.7M | 2.18% |
90,000
+11,900
| +15% | +$1.53M |
|
10
Atlanta Braves Holdings Series B
BATRK
$3.23B
| $10.6M | 2.14% |
380,000
-20,000
| -5% | -$550K |
|
11
Intuitive Surgical
ISRG
$121B
| $10.3M | 2.09% |
54,000
-3,000
| -5% | -$533K |
|
12
DexCom
DXCM
$27.6B
| $9.53M | 1.94% |
320,000
-38,000
| -11% | -$1.34M |
|
|
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.52M | 1.94% |
+56,500
| New | +$8.41M |
|
14
Amazon
AMZN
$2.5T
| $9.43M | 1.92% |
105,900
+25,900
| +32% | +$2.16M |
|
15
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $9.05M | 1.84% |
100,000
-230,000
| -70% | -$19.6M |
|
16
New York Times
NYT
$11.6B
| $8.97M | 1.82% |
273,000
+38,000
| +16% | +$1.12M |
|
|
GRA
17
DELISTED
W.R. Grace & Co.
GRA
| $8.9M | 1.81% |
114,000
+15,000
| +15% | +$1.11M |
|
|
ARNA
18
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.74M | 1.78% |
195,000
+15,000
| +8% | +$688K |
|
|
SAGE
19
CALL
DELISTED
Sage Therapeutics
SAGE
| $8.35M | 1.7% |
+52,500
| New | +$7.6M |
|
20
PUT
ResMed
RMD
$28.3B
| $8.32M | 1.69% |
+80,000
| New | +$8.26M |
|
21
RingCentral
RNG
$4.05B
| $8.03M | 1.63% |
74,500
-11,500
| -13% | -$1.13M |
|
22
Inspire Medical Systems
INSP
$1.42B
| $7.89M | 1.6% |
139,000
+4,000
| +3% | +$216K |
|
|
23
Atlassian
TEAM
$22B
| $7.75M | 1.58% |
+69,000
| New | +$7.05M |
|
24
Ashland
ASH
$3.04B
| $7.58M | 1.54% |
97,000
+52,800
| +119% | +$4.07M |
|
25
Roku
ROKU
$21.1B
| $7.55M | 1.53% |
+117,000
| New | +$6.26M |
|
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Atika Capital Management held 98 positions worth $492M, up 45% from $340M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Atika Capital Management deployed $82.8M of net new capital in Q1 2019, opening 29 new positions and adding to 22 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 56,500 shares worth $9.52M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was eHealth, an estimated $5.9M trimmed.
- Atika Capital Management's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 56,500 shares worth $9.52M.
- Atika Capital Management added most to Arista Networks in Q1 2019, an estimated $7.11M increase.
- Atika Capital Management's biggest Q1 2019 reduction was eHealth, cutting an estimated $5.9M.
- Atika Capital Management fully exited Elevance Health in Q1 2019, selling an estimated $6.7M.
- Atika Capital Management's ten largest holdings make up 34% of its $492M portfolio in Q1 2019.
- Atika Capital Management opened 29 new positions and closed 26 in Q1 2019.
- Atika Capital Management's portfolio value rose 45% quarter-over-quarter to $492M.
Based on Atika Capital Management's 13F filing for Q1 2019, filed 13 May 2019.